Introduction to Clinical Pharmacology and Therapeutics - Pharmacokinetic Concepts - Part 2
NIH Clinical Center via YouTube
Overview
Syllabus
Clinical Pharmacology
Pharmacokinetics - Pharmacodynamics
USES OF PHARMACOKINETICS
Dose-Response Relationship
"Target concentration" strategy
FIRST DESCRIPTION OF THERAPEUTIC DRUG MONITORING
DRUG CANDIDATES FOR TDM
TARGET CONCENTRATION STRATEGY
TRADITIONAL Guidelines for DIGOXIN Levels
SURVIVAL as a function of DIGOXIN LEVEL measured after 1 Month Rx
3 DISTRIBUTION VOLUMES
INITIAL DIGITALIZATION
DISTRIBUTION DELAYS ONSET of DIGOXIN Chronotropic Action
ELIMINATION HALF-LIFE
ELIMINATION PARAMETERS
MAINTENANCE DIGOXIN THERAPY
CUMULATION FACTOR
ELIMINATION RATE CONSTANT
LOADING & MAINTENANCE DOSES
CREATININE CLEARANCE EQUATION
MDRD Study Equation
CKD-EPI Collaboration Equation
STEADY STATE CONCENTRATION
PHENYTOIN KINETICS in Normal Subjects
STEADY STATE EQUATIONS
RELATIONSHIP OF PLASMA LEVEL TO PHENYTOIN DOSE
PATIENT WHO BECAME TOXIC ON A PHENYTOIN DOSE OF 300 mg/day
BASIS OF APPARENT FIRST-ORDER KINETICS
Taught by
NIH Clinical Center